Skip to content

Advertisement

  • Review
  • Open Access

M cell-dependent antigen uptake on follicle-associated epithelium for mucosal immune surveillance

Inflammation and Regeneration201838:15

https://doi.org/10.1186/s41232-018-0072-y

  • Received: 29 March 2018
  • Accepted: 28 May 2018
  • Published:

Abstract

The follicle-associated epithelium (FAE) covering mucosa-associated lymphoid tissue is distinct from the villous epithelium in cellular composition and functions. Interleukin-22 binding protein (IL-22BP), provided by dendritic cells at the sub-epithelial dome region, inhibits the IL-22-mediated secretion of antimicrobial peptides by the FAE. The Notch signal from stromal cells underneath the FAE diminishes goblet cell differentiation. These events dampen the mucosal barrier functions to allow luminal microorganisms to readily gain access to the luminal surface of the FAE. Furthermore, receptor activator of nucleic factor-kappa B ligand (RANKL) from a certain stromal cell type induces differentiation into microfold (M) cells that specialize in antigen uptake in the mucosa. Microfold (M) cells play a key role in mucosal immune surveillance by actively transporting external antigens from the gut lumen to the lymphoid follicle. The molecular basis of antigen uptake by M cells has been gradually identified in the last decade. For example, GPI-anchored molecules (e.g., glycoprotein 2 (GP2) and cellular prion protein (PrPC)) and β1-integrin facilitate the transport of specific types of xenobiotics. The antigen transport by M cells initiates antigen-specific mucosal immune responses represented by the induction of secretory immunoglobulin A (S-IgA). Meanwhile, several invasive pathogens exploit M cells as a portal to establish a systemic infection. Recent findings have uncovered the molecular machinery of differentiation and functions of M cells.

Keywords

  • FAE
  • M cell
  • Mucosal immune surveillance
  • Antigen uptake
  • Mucosa-associated lymphoid tissue (MALT)
  • Mucosal infection

Background

Epithelial cells lining on the body surface play essential roles in various tissue functions, including respiration, digestion, reproduction, and evacuation. The epithelium is continuously exposed to external materials, which entails the risks of encountering a lot of pathogens (e.g., bacteria, viruses, and parasites) and their toxins. Indeed, various kinds of pathogens invade a host body through mucosal epithelial layers to cause infectious diseases, such as salmonellosis, hemorrhagic colitis, shigellosis, tuberculosis, influenza, and acquired immunodeficiency syndrome (AIDS). Moreover, a multitude of microbes colonize mucosal tissue, particularly human intestine, which harbor approximately 40 trillion bacteria [1, 2]. To deal with such a microbial burden, a unique immune system, termed “the mucosal immune system,” has evolved in vertebrates. The mucosal immune system is unambiguously distinguished from the systemic immune system in terms of cellular composition, antigen recognition, and effector functions.

One of the most characteristic features of the mucosal immune system is inherent lymphoid tissue called the mucosa-associated lymphoid tissue (MALT). MALT consists of multiple or solitary lymphoid follicles covered by the follicle-associated epithelium (FAE) with a dome-like shape. These well-organized lymphoid structures are constitutively found in the intestinal and nasopharyngeal tracts and are inducible in the bronchial tissue [3]. The systemic lymphoid tissue, namely the spleen and peripheral lymph nodes, activates the immune response to antigens from the blood vessels and afferent vessels, respectively. Meanwhile, MALT directly takes up antigens from the lumen across the FAE to induce the mucosal immune response. Thus, the mucosal immune system continuously monitors exogenous antigens on the mucosal surface for immune surveillance.

The antigen internalization via the FAE was initially found by Kenzaburo Kumagai in 1922 [4]. However, the cellular entity responsible for the antigen transport had been unclear for half a century since the finding, mainly owing to technical difficulties. In the 1970s, by taking advantage of the development of electron microscopy, Max Cooper found the specialized epithelial cells that play a key role in the antigen uptake in the FAE in the bursa of Fabricius [5]. Concomitantly, Robert Owen revealed a similar cell type in human Peyer’s patches and named it microfold (M) cells [6, 7]. It is well known that antigen uptake through microfold (M) cells contributes to the induction of antigen-specific immunoglobulin A (IgA), a dominant isotype in secretory fluids of most mucosal tissues, except for the respiratory and genital tract [8]. IgA secreted into the mucosal lumen binds to luminal commensal and pathogenic microbes to prevent microbial adhesion to epithelial cells. Therefore, antigen uptake by M cells is considered to be critical for the onset of the mucosal immune response. Recent studies have uncovered the molecular basis of differentiation and functions of M cells. In this review, we discuss current knowledge of development and antigen uptake in the FAE and M cells.

Formation of Peyer’s patches and the FAE

Formation of MALT, especially Peyer’s patches (PP), during developmental stages has been well documented. Anlagen of mouse PPs are found at 15 days postcoitus in mice [9]. In the primordial PPs, lymphotoxin α1β2 (LTα1β2)-expressing lymphoid tissue inducer (LTi) cells stimulate LTβR-expressing lymphoid tissue organizer (LTo) cells to produce chemokines (e.g., CXCL13) and adhesion molecules (e.g., VCAM-1) involved in the recruitment and organization of lymphocytes [10]. At embryonic day 17.5 (E17.5), the dome-shaped FAE is established, and it produces CCL20 to attract CCR6-expressing B cells and immature CD11b+ dendritic cells [1113]. Transcriptome analysis illustrated a distinct gene expression profile between the FAE and the villous epithelium [14]. Remarkably, several chemokines (Ccl6, Ccl9, Ccl20, Ccl26, and Cxcl16) are highly upregulated in the FAE [1517]. Expressions of these chemokines are mainly controlled by signaling through the LTβR and receptor activator of nucleic factor-kappa B (RANK; TNFRSF11A). Genetic ablation of RANK signaling diminishes Ccl20 expression in gut-associated lymphoid tissue (GALT) [18]. In human, the clusters of lymphocytes are identified in small intestine at 14–16 weeks of gestation, and PPs are microscopically observable at gestational age of 24 weeks [19]. After birth, human PPs greatly expand early in life [19, 20].

The FAE in PP is formed at the late stage of fetal development as described above. We previously reported that LTo cell-mediated activation of epithelial Notch signaling contributes to the organization and integrity of the FAE [21]. Activation of epithelial Notch signaling suppresses goblet cell differentiation as described below and secures CCL20 expression in the FAE, facilitating full maturation of PPs and isolated lymphoid follicles. The maturation of MALT also necessitates antigen transport via M cells. In support of this idea, mice lacking M cells because of deficiency in RANK in intestinal epithelium or nucleic factor-kappa B ligand (RANKL) in sub-epithelial mesenchymal cells [known as M cell inducer (MCi)] of GALTs display the reduced size of PPs in association with inactivation of the germinal center reaction [18, 22]. Thus, FAE-intrinsic Notch signaling as well as antigen exposure is essential for the maturation of GALTs. Luminal antigens are also indispensable for the establishment of the overall mucosal immune system. Antigen-free mice that are raised and bred on an elemental diet, devoid of dietary antigens under germ-free conditions, exhibited a marked reduction of lymphocytes in the small intestinal lamina propria and mesenteric lymph nodes, but not in the spleen [23].

Characterization of the FAE

Intestinal epithelial cells constitute a front-line barrier for the prevention of invasive microorganisms. For instance, intercellular tight junctions provide a robust physical barrier by securing close connections between adjacent cells [24]. Polymeric immunoglobulin receptor (pIgR) expressed on the basolateral plasma membrane of epithelial cells transports dimeric IgA to the lumen [25]. Furthermore, Atoh1/Math1+ intestinal secretory cell lineages, such as goblet cells, play central roles in the establishment of physicochemical barriers by secreting mucin [26]. These molecules are a prerequisite for segregation of microbial habitats from the epithelial surface [27]. In sharp contrast to the ordinary villous epithelium, the FAE is mainly composed of enterocytes and M cells with a limited number of goblet cells. The mucin layer is therefore thinner in the FAE region than in the villous region [28]. The hypoplastic mucin layer allows luminal antigens to readily gain access to the FAE (Fig. 1).
Fig. 1
Fig. 1

M cells in the FAE specialize in antigen uptake on the mucosal surface. To protect against bacterial invasion, the villous epithelium is equipped with robust mucosal barriers composed of tight junctions, thick mucin layer, S-IgA, and AMPs. In contrast, the FAE is vulnerable because of a thin mucin layer and downregulation of the expression of polymeric immunoglobulin receptor (pIgR) and AMPs. Consequently, external antigens are able to easily gain access to M cells on the FAE. The expression of the Notch ligand and IL-22BP in the sub-epithelial region, at least partially, account for the attenuated barrier functions

The differentiation of goblet cells is controlled by the Notch signal that is widely utilized for cell-cell interaction in various cell types [26]. In the intestinal villi, secretory-type epithelial cells express Notch ligands (e.g., Dll1) to bind Notch receptors in adjacent epithelial cells [29, 30]. The ligation of the ligands liberates the Notch intracellular domain (NICD), which translocates into the nucleus to form a transcriptional activator complex with the recombination signal binding protein for immunoglobulin κ J region (RBP-J). The NICD/RBP-J complex upregulates the expression of Hes1, which in turn represses the expression of Atoh1, the main regulator of secretory cell lineages [26, 31, 32]. Consequently, activation of the Notch signal in intestinal epithelial cells limits the number of secretory cells and maintains the balance between absorptive and secretory epithelial cell populations. Such self-regulation of epithelial cell populations in the intestine is termed lateral inhibition. In PPs, stromal cells beneath the FAE constitutively express a Notch ligand, Dll1 [21, 33], indicating that secretory cell lineages in the FAE are suppressed by stromal Notch ligands (Fig. 1). The inactivation of the Notch signal by genetic ablation of RBP-J in intestinal epithelial cells (RBP-JΔIEC) markedly increases the number of goblet cells in both the FAE and villous epithelium [21]. As a consequence, RBP-JΔIEC mice are defective in maturation of PPs and isolated lymphoid follicles at least partly because of downregulated expression of CCL20, which is mainly produced by enterocytes, but not goblet cells, during the developmental stage.

In addition, Paneth cells abundantly produce antimicrobial products (AMPs) like lysozyme, RegIIIγ, and α-defensins (cryptdins) in response to cholinergic nerve activation and stimuli with microbial products [34, 35]. Enterocytes in the intestinal villi also produce AMPs, such as RegIIIγ and β-defensins [34, 36, 37]. However, the expression of the AMPs remarkably decreases in the FAE as compared with the villus epithelium. Interleukin-22 (IL-22), produced by type 3 innate lymphoid cells (ILC3) and T helper 17 (Th17) cells in the lamina propria, upregulates the expression of AMPs [38, 39]. IL-22 signaling is ameliorated in the FAE. This is attributed to constitutive expression of IL-22-binding protein (IL-22BP), a secreted decoy receptor for IL-22, which is abundantly provided by immature dendritic cells at the SED of PPs [40] (Fig. 1). Expression of pIgR is also downregulated in the FAE [41], although the underlying mechanism remains to be clarified. Collectively, the cellular components of PPs, namely epithelial cells, dendritic cells, and stromal cells, are responsible for the establishment of a specialized microenvironment that facilitates uptake of mucosal antigens.

Differentiation of M cells

M cells account for approximately 10% of FAE cells in mouse PPs (Fig. 2a) [28]. M cells can be identified by electron microscopy owing to their characteristic morphology: sparse and irregular microvilli, called microfold, as well as an invaginated basal plasma membrane to form the pocket-like structure that is occupied by immunocompetent cells [5, 6]. Although M cells were anatomically identified in the 1970s, technical difficulties in isolation and culture of M cells had hampered further analyses to elucidate their differentiation and functions. To deal with this issue, we previously established a method to isolate the FAE and successfully performed transcriptome analysis followed by in situ hybridization to determine M cell-specific molecules [14, 42]. Consequently, the course of analysis led to the identification of several M cell-specific markers including CCL9, Sgne-1, and GP2. Furthermore, recent progress uncovered the key molecules that govern the differentiation of M cells. Williams and colleagues revealed that RANKL (TNFSF11) is essential for the differentiation of M cells [43]. As described earlier, RANKL is provided from stromal MCi cells residing underneath the FAE of GALT (Fig. 2) [18]. Because intestinal epithelial cells constitutively express a RANKL receptor, RANK (TNFRSF11A), intraperitoneal administration of recombinant RANKL ectopically induces differentiation of the M cell-like GP2+ cells in the intestinal villous region [43, 44]. Of note, M cells scattered in the intestinal villi of RANKL-treated mice and the FAE of untreated mice, suggesting existence of potential machinery to regulate the number of M cells. Because we observed that deficiency in RBP-J did not increase the number of M cells (Hase K et al., unpublished observation), lateral inhibition via Notch signaling should be excluded in the regulation of M cell number.
Fig. 2
Fig. 2

Expression of M cell marker molecules during differentiation. a Fluorescence in situ hybridization (FISH) image of Spib, M-Sec, and Gp2 in a mouse FAE specimen is shown. Premature and immature M cells are observed at the crypt and the periphery of dome region, respectively, whereas fully mature M cells are found at the middle and upper dome region. b Enlarged images of the cypt region are shown. c RANKL from stromal M cell inducer (MCi) cells stimulates intestinal stem cells to initiate M cell differentiation. Early (Marksl1, AnnexinV), intermediate (Spi-B, Tnfaip2, CCL9), and mature (GP2) markers are serially expressed during the course of differentiation

The stimulation with RANKL activates NF-κB family in both canonical (NF-κB1 p50, RelA, and c-Rel) and non-canonical (NF-κB2 p52 and RelB) pathways [45]. The RANKL treatment in aly/aly mice carrying a point mutation of NF-κB inducing kinase (NIK) gene failed to induce M cells in the intestinal villi [46, 47]. Because NIK acts as a specific component of the non-canonical NF-κB pathway [48], this result suggested that the RANKL-induced non-canonical NF-κB pathway is essential for M cell differentiation. Recent studies reported that M cell differentiation was dependent on non-canonical RelB pathway, but not canonical c-Rel [46, 47, 49]. However, the canonical NF-κB pathway supports M cell differentiation by enhancing the expression of Relb and Nfkb2 in enteroids stimulated with TNF-α [47].

Over the course of differentiation, M cells differentially express several molecular markers [5052], suggesting that M cells undergo stepwise maturation processes (Fig. 2b). This concept was supported by a current single-cell transcriptome analysis that clearly demonstrated molecular signatures of early and late M cell progenitors, and immature and fully mature M cells [53].

Indeed, Marcksl1 and Anx5 are expressed in M cell progenitors and villus epithelial cells immediately after intraperitoneal treatment with RANKL [44, 53]. In contrast, Spi-B, Ccl9, and Tnfaip2 (also termed M-sec) were recognized as immature M cell makers [53]. Among these molecules, Spi-B plays a pivotal role in the development of fully differentiated M cells. Glycoprotein-2 (GP2)-positive mature M cells are absent in PPs of Spib−/− mice, whereas Marcksl1+AnnexinV+ immature M cells are intact [44]. Furthermore, Spib−/− mice reveal much less uptake of pathogenic bacteria, such as Salmonella enterica serovar Typhimurium (Salmonella Typhimurium) and Yersinia enterocolitica [44]. Collectively, the nuclear translocation of RelB and the expression of transcription factor Spi-B are essential for the RANKL-induced differentiation of M cells. In contrast, the commensal bacteria Alcaligenes can be internalized into GALT of Spib−/− mice [54, 55], indicating that immature M cells may take up this PP-colonizing bacteria. Alternatively, the epithelial cell-independent trans-epithelial antigen sampling by mononuclear phagocytes may mediate the internalization of Alcaligenes in PPs [56]. This observation implies that antigen uptake of certain bacteria in the FAE does not always necessitate mature M cells.

Antigen uptake receptors in M cells

Recent studies demonstrated that M cells utilize several receptors to recognize and transport specific luminal antigens. GP2 is a GPI-anchored protein expressed on the apical surface of M cells to function as an uptake receptor for type I pili-expressing bacteria (e.g., S. Typhimurium and Escherichia coli) (Fig. 3) [42]. GP2 also binds hemagglutinin A1 of botulinum neurotoxin, increasing susceptibility to botulism [57]. M cells highly express other GPI-anchored membrane proteins, cellular prion protein (PrPC) and uromodulin (Umod)/Tamm-Horsfall protein (THP), which serve as uptake receptors for Brucella abortus and Lactobacillus acidophilus, respectively [55, 58, 59]. In addition, β1-integrin localized on the apical surface of M cells facilitates transcytosis of Yersinia spp. [58, 60] (Fig. 3). These observations illustrate that M cells express multiple receptors on their apical plasma membrane to efficiently take up certain microbes. Although the uptake receptors have been extensively analyzed during this decade, the intracellular trafficking machinery regulating the antigen transcytosis remains largely unknown. A current study revealed that Allograft inflammation factor 1 (Aif1), which is known to be involved in phagocytosis in macrophages [61], is specifically upregulated in M cells among intestinal epithelial cells. Aif1 plays a non-redundant role in the activation of β1-integrin and facilitates the uptake of Y. enterocolitica [60]. Furthermore, transcriptome analysis of M cells demonstrated that M cells abundantly express a substantial number of intracellular molecules, potentially contributing to vesicular transport or actin remodeling during the course of the transcytotic pathway [53]. Functional analyses of these molecules should open up a new research direction on the molecular mechanism of M cell-specific antigen transport.
Fig. 3
Fig. 3

Antigen uptake receptors on the apical surface of M cells. GP2 binds to the HA1 domain of the botulinum toxin and FimH+ type 1 pili of certain bacterial species. PrPC facilitates internalization of Brucella abortus into M cells. Umod serves as an uptake receptor for Lactobacillus acidophilus. β1-integrin is activated by Aif1 to function as an uptake receptor for Yersinia spp. Antigens taken up by M cells are transcytosed to an M cell pocket, whereby antigen-presenting cells, like dendritic cells, capture the antigens

M cell as a portal for infectious agents

Several invasive bacteria are known to exploit M cells to invade the host body. S. Typhimurium and Shigella spp. gain entry to Peyer’s patches through M cells [6264]. Furthermore, M cells take up scrapie prion protein (PrPSc) from food and thus potentially contribute to the accumulation of PrPSc in follicular dendritic cells of PPs [65]. The deletion of M cells moderates the pathogenesis of prion’s disease [66]. In addition to the foodborne pathogens, the airborne pathogen Mycobacterium tuberculosis also invades the host body via M cells in nasopharynx-associated lymphoid tissues (NALTs) and bronchus-associated lymphoid tissues (BALTs) [67]. These findings indicate that M cells function as an initial step of both mucosal immunity and pathogenesis, and this character is often referred to as the “double-edged sword” [68].

However, little is known about whether M cell-dependent antigen uptake predominantly contributes to immune responses against infection or bacterial invasion. Our current study reveals that M cell-null mice are highly susceptible to the mucosal infection of non-invasive pathogens, indicating that M cell-mediated antigen transport is important for the host defenses against, at least, non-invasive pathogens (Nakamura et al. unpublished observation). Recent studies have revealed that gastrointestinal microbiota is implicated in the development of multiple diseases, such as diabetes, obesity, multiple sclerosis, and autism spectrum disorder [69]. There is an open question whether M cell-mediated antigen transport and the subsequent immune response could regulate the commensal microbiota. Further investigations may uncover novel links among M cells, mucosal immunity, and the gut microbiota.

Conclusion

Recent findings have provided new insights into the molecular basis of antigen transport on the mucosal surface. In particular, identification of receptors specific for pathogens and/or commensals on M cells exemplify selective uptake of particular antigens for mucosal immunosurveillance. Because M cell-mediated antigen uptake contributes to the induction of antigen-specific secretory immunoglobulin A (S-IgA), the uptake receptors on M cells may be a promising target for mucosal vaccination to efficiently induce pathogen-specific S-IgA [7072]. S-IgA not only suppresses pathogenic infection but also shapes the gut microbial community. Alteration of the gut microbial composition is a predisposing factor for various diseases including diabetes, obesity, non-alcoholic steatohepatitis, multiple sclerosis, and autism spectrum disorder [69]. It is therefore intriguing to evaluate the role of M cells in the regulation of the gut microbiota, as well as the development of the diseases associated with dysbiosis. Further investigation employing M cell-null mice will shed light on the biological significance of M cells.

Abbreviations

AIDS: 

Acquired immunodeficiency syndrome

Aif1: 

Allograft inflammation factor 1

AMPs: 

Antimicrobial proteins

BALT: 

Bronchus-associated lymphoid tissue

FAE: 

Follicle-associated epithelium

GALT: 

Gut-associated lymphoid tissue

GP2: 

Glycoprotein 2

IgA: 

Immunoglobulin A

IL-22: 

Interleukine-22

IL-22BP: 

Interleukine-22 binding protein

ILC3: 

Type 3 innate lymphoid cell

LTi: 

Lymphoid tissue inducer

LTo: 

Lymphoid tissue organizer

LTα1β2

Lymphotoxin α1β2

M cell: 

Microfold cell

MALT: 

Mucosa-associated lymphoid tissue

MCi cell: 

Microfold cell inducer cell

NALT: 

Nose-associated lymphoid tissue

NICD: 

Notch intracellular domain

NIK: 

NF-κB inducing kinase

pIgR: 

Polymeric immunoglobulin receptor

PP: 

Peyer’s patch

PrPC

Cellular prion protein

PrPSc

Scrapie prion protein

RANK: 

Receptor activator of nucleic factor-kappa B

RANKL: 

Receptor activator of nucleic factor-kappa B ligand

RBP-J: 

Recombination signal binding protein for immunoglobulin κ J region

S-IgA: 

Secretory immunoglobulin A

Th17: 

T helper 17

THP: 

Tamm-Horsfall protein

Umod: 

Uromodulin

Declarations

Acknowledgements

This work was supported partly by the Grants from the Joint Research Project of the Institute of Medical Science, the University of Tokyo (K.H.), and the Joint Research Program of the Institute for Genetic Medicine, Hokkaido University (K.H.).

Funding

This work was funded by JSPS KAKENHI (Grant number: 17H04089 to KH), MEXT KAKENHI (Grant numbers: 16H01369 and 26116709 to KH), AMED-Crest (KH), Takeda Science Foundation (KH), and The NOVARTIS Foundation JAPAN for Promotion of Science (KH).

Authors’ contributions

YN and KH wrote the manuscript. SK provided the immunofluorescence staining data. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Division of Biochemistry, Faculty of Pharmacy, Keio University, Tokyo 105-0011, Japan
(2)
Graduate School of Medicine, The University of Tokyo, Tokyo 108-8639, Japan
(3)
Laboratory of Histology and Cytology, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan
(4)
International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan

References

  1. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107–33.View ArticlePubMedGoogle Scholar
  2. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S, Woodland DL, Lund FE, Randall TD. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med. 2004;10:927–34.View ArticlePubMedGoogle Scholar
  4. Kumagai K. Keitaitekiseibun no tyoukan kyusyu kikou ni tsuite (Japanese). Osaka igakukai. 1922;21:497–522.Google Scholar
  5. Bockman DE, Cooper MD. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study. Am J Anat. 1973;136:455–77.View ArticlePubMedGoogle Scholar
  6. Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology. 1974;66:189–203.PubMedGoogle Scholar
  7. Owen RL. Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer’s patches in the normal unobstructed mouse intestine: an ultrastructural study. Gastroenterology. 1977;72:440–51.PubMedGoogle Scholar
  8. Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol Rev. 2005;206:64–82.View ArticlePubMedGoogle Scholar
  9. Hashi H, Yoshida H, Honda K, Fraser S, Kubo H, Awane M, Takabayashi A, Nakano H, Yamaoka Y, Nishikawa S-I. Compartmentalization of Peyer’s patch anlagen before lymphocyte entry. J Immunol. 2001;166:3702–9.View ArticlePubMedGoogle Scholar
  10. Luther SA, Ansel KM, Cyster JG. Overlapping roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development. J Exp Med. 2003;197:1191–8.View ArticlePubMedPubMed CentralGoogle Scholar
  11. McDonald KG, McDonough JS, Wang C, Kucharzik T, Williams IR, Newberry RD. CC chemokine receptor 6 expression by B lymphocytes is essential for the development of isolated lymphoid follicles. Am J Pathol. 2007;170:1229–40.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Rumbo M, Sierro F, Debard N, Kraehenbuhl J-P, Finke D. Lymphotoxin beta receptor signaling induces the chemokine CCL20 in intestinal epithelium. Gastroenterology. 2004;127:213–23.View ArticlePubMedGoogle Scholar
  13. Iwasaki A, Kelsall BL. Localization of distinct Peyer’s patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (Mip)-3α, Mip-3β, and secondary lymphoid organ chemokine. J Exp Med. 2000;191:1381–94.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Hase K. Distinct gene expression profiles characterize cellular phenotypes of follicle-associated epithelium and M cells. DNA Res. 2005;12:127–37.View ArticlePubMedGoogle Scholar
  15. Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 2013;6:666–77.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Hase K, Murakami T, Takatsu H, Shimaoka T, Iimura M, Hamura K, Kawano K, Ohshima S, Chihara R, Itoh K, Yonehara S, Ohno H. The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT. J Immunol. 2006;176:43–51.View ArticlePubMedGoogle Scholar
  17. Zhao X, Sato A, Cruz Dela CS, Linehan M, Luegering A, Kucharzik T, Shirakawa A-K, Marquez G, Farber JM, Williams I, Iwasaki A. CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer’s patch CD11b+ dendritic cells. J Immunol. 2003;171:2797–803.View ArticlePubMedGoogle Scholar
  18. Nagashima K, Sawa S, Nitta T, Tsutsumi M, Okamura T, Penninger JM, Nakashima T, Takayanagi H. Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nat Immunol. 2017;18:675–82.View ArticlePubMedGoogle Scholar
  19. Jung C, Hugot J-P, Barreau F. Peyer’s patches: the immune sensors of the intestine. Int J Inflam. 2010;2010:823710–2.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Cornes JS. Number, size, and distribution of Peyer’s patches in the human small intestine: part I the development of Peyer’s patches. Gut. 1965;6:225.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Obata Y, Kimura S, Nakato G, Iizuka K, Miyagawa Y, Nakamura Y, Furusawa Y, Sugiyama M, Suzuki K, Ebisawa M, Fujimura Y, Yoshida H, Iwanaga T, Hase K, Ohno H. Epithelial-stromal interaction via notch signaling is essential for the full maturation of gut-associated lymphoid tissues. EMBO Rep. 2014;15:1297–304.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Rios D, Wood MB, Li J, Chassaing B, Gewirtz AT, Williams IR. Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria. Mucosal Immunol. 2016;9:907–16.View ArticlePubMedGoogle Scholar
  23. Kim KS, Hong S-W, Han D, Yi J, Jung J, Yang B-G, Lee JY, Lee M, Surh CD. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science. 2016;351:858–63.View ArticlePubMedGoogle Scholar
  24. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2:285.View ArticlePubMedGoogle Scholar
  25. Rojas R, Apodaca G. Immunoglobulin transport across polarized epithelial cells. Nat Rev Mol Cell Biol. 2002;3:944.View ArticlePubMedGoogle Scholar
  26. Yang Q. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 2001;294:2155–8.View ArticlePubMedGoogle Scholar
  27. Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A. 2008;105:15064–9.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Ohno H. Intestinal M cells. J Biochem. 2016;159:151–60.View ArticlePubMedGoogle Scholar
  29. van Es JH, Sato T, van de Wetering M, Lyubimova A, Gregorieff A, Zeinstra L, van den Born M, Korving J, Martens ACM, van den Oudenaarden A, Clevers H. Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol. 2012;14:1099–104.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Sancho R, Cremona CA, Behrens A. Stem cell and progenitor fate in the mammalian intestine: notch and lateral inhibition in homeostasis and disease. EMBO Rep. 2015;16:571–81.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature. 2005;435:964–8.View ArticlePubMedGoogle Scholar
  32. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, Robine S, Winton DJ, Radtke F, Clevers H. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005;435:959–63.View ArticlePubMedGoogle Scholar
  33. Mach J, Hshieh T, Hsieh D, Grubbs N, Chervonsky A. Development of intestinal M cells. Immunol Rev. 2005;206:177–89.View ArticlePubMedGoogle Scholar
  34. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol. 2000;1:113.View ArticlePubMedGoogle Scholar
  35. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313:1126–30.View ArticlePubMedPubMed CentralGoogle Scholar
  36. O’Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 1999;163:6718–24.PubMedGoogle Scholar
  37. Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol. 2012;12:503–16.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Artis D, Spits H. The biology of innate lymphoid cells. Nature. 2015;517:293–301.View ArticlePubMedGoogle Scholar
  39. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14:282–9.View ArticlePubMedGoogle Scholar
  40. Jinnohara T, Kanaya T, Hase K, Sakakibara S, Kato T, Tachibana N, Sasaki T, Hashimoto Y, Sato T, Watarai H, Kunisawa J, Shibata N, Williams IR, Kiyono H, Ohno H. IL-22BP dictates characteristics of Peyer's patch follicle-associated epithelium for antigen uptake. J Exp Med. 2017;214:1607–18.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Bjerke K, Brantzaeg P. Lack of relation between expression of HLA-DR and secretory component (SC) in follicle-associated epithelium of human Peyer’s patches. Clin Exp Immunol. 1988;71:502.PubMedPubMed CentralGoogle Scholar
  42. Hase K, Kawano K, Nochi T, Pontes GS, Fukuda S, Ebisawa M, Kadokura K, Tobe T, Fujimura Y, Kawano S, Yabashi A, Waguri S, Nakato G, Kimura S, Murakami T, Iimura M, Hamura K, Fukuoka S-I, Lowe AW, Itoh K, Kiyono H, Ohno H. Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response. Nature. 2009;462:226–30.View ArticlePubMedGoogle Scholar
  43. Knoop KA, Kumar N, Butler BR, Sakthivel SK, Taylor RT, Nochi T, Akiba H, Yagita H, Kiyono H, Williams IR. RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J Immunol. 2009;183:5738–47.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Kanaya T, Hase K, Takahashi D, Fukuda S, Hoshino K, Sasaki I, Hemmi H, Knoop KA, Kumar N, Sato M, Katsuno T, Yokosuka O, Toyooka K, Nakai K, Sakamoto A, Kitahara Y, Jinnohara T, McSorley SJ, Kaisho T, Williams IR, Ohno H. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat Immunol. 2012;13:729–36.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693–733.View ArticlePubMedGoogle Scholar
  46. Kimura S, Yamakami-Kimura M, Obata Y, Hase K, Kitamura H, Ohno H, Iwanaga T. Visualization of the entire differentiation process of murine M cells: suppression of their maturation in cecal patches. Mucosal Immunol. 2015;8:650–60.View ArticlePubMedGoogle Scholar
  47. Wood MB, Rios D, Williams IR. TNF-α augments RANKL-dependent intestinal M cell differentiation in enteroid cultures. Am J Physiol, Cell Physiol. 2016;311:C498–507.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Sun S-C. Non-canonical NF-κB signaling pathway. Cell Res. 2011;21:71–85.View ArticlePubMedGoogle Scholar
  49. Sehgal A, Kobayashi A, Donaldson DS, Mabbott NA. c-Rel is dispensable for the differentiation and functional maturation of M cells in the follicle-associated epithelium. Immunobiology. 2017;222:316–26.View ArticlePubMedPubMed CentralGoogle Scholar
  50. Hase K, Kimura S, Takatsu H, Ohmae M, Kawano S, Kitamura H, Ito M, Watarai H, Hazelett CC, Yeaman C, Ohno H. M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex. Nat Cell Biol. 2009;11:1427–U91.View ArticlePubMedGoogle Scholar
  51. Terahara K, Yoshida M, Igarashi O, Nochi T, Pontes GS, Hase K, Ohno H, Kurokawa S, Mejima M, Takayama N, Yuki Y, Lowe AW, Kiyono H. Comprehensive gene expression profiling of Peyer’s patch M cells, villous M-like cells, and intestinal epithelial cells. J Immunol. 2008;180:7840–6.View ArticlePubMedGoogle Scholar
  52. de Lau W, Kujala P, Schneeberger K, Middendorp S, Li VSW, Barker N, Martens A, Hofhuis F, DeKoter RP, Peters PJ, Nieuwenhuis E, Clevers H. Peyer’s patch M cells derived from Lgr5+ stem cells require SpiB and are induced by RankL in cultured “miniguts”. Mol Cell Biol. 2012;32:3639–47.View ArticlePubMedPubMed CentralGoogle Scholar
  53. Haber AL, Biton M, Rogel N, Herbst RH, Shekhar K, Smillie C, Burgin G, Delorey TM, Howitt MR, Katz Y, Tirosh I, Beyaz S, Dionne D, Zhang M, Raychowdhury R, Garrett WS, Rozenblatt-Rosen O, Shi HN, Yilmaz O, Xavier RJ, Regev A. A single-cell survey of the small intestinal epithelium. Nature. 2017;551:333–9.View ArticlePubMedGoogle Scholar
  54. Obata T, Goto Y, Kunisawa J, Sato S, Sakamoto M, Setoyama H, Matsuki T, Nonaka K, Shibata N, Gohda M, Kagiyama Y, Nochi T, Yuki Y, Fukuyama Y, Mukai A, Shinzaki S, Fujihashi K, Sasakawa C, Iijima H, Goto M, Umesaki Y, Benno Y, Kiyono H. Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci U S A. 2010;107:7419–24.View ArticlePubMedPubMed CentralGoogle Scholar
  55. Sato S, Kaneto S, Shibata N, Takahashi Y, Okura H, Yuki Y, Kunisawa J, Kiyono H. Transcription factor Spi-B-dependent and -independent pathways for the development of Peyer’s patch M cells. Mucosal Immunol. 2013;6:838–46.View ArticlePubMedGoogle Scholar
  56. Lelouard H, Fallet M, de Bovis B, Méresse S, Gorvel J-P. Peyer’s patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology. 2012;142:592–601.e3.View ArticlePubMedGoogle Scholar
  57. Matsumura T, Sugawara Y, Yutani M, Amatsu S, Yagita H, Kohda T, Fukuoka S-I, Nakamura Y, Fukuda S, Hase K, Ohno H, Fujinaga Y. Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity. Nat Commun. 2015;6:6255.View ArticlePubMedPubMed CentralGoogle Scholar
  58. Clark MA, Hirst BH, Jepson MA. M-cell surface β1 integrin expression and Invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer’s patch M cells. Infect Immun. 1998;66:1237–43.PubMedPubMed CentralGoogle Scholar
  59. Yanagihara S, Kanaya T, Fukuda S, Nakato G, Hanazato M, Wu X-R, Yamamoto N, Ohno H. Uromodulin-SlpA binding dictates lactobacillus acidophilus uptake by intestinal epithelial M cells. Int Immunol. 2017;29:357–63.View ArticlePubMedGoogle Scholar
  60. Kishikawa S, Sato S, Kaneto S, Uchino S, Kohsaka S, Nakamura S, Kiyono H. Allograft inflammatory factor 1 is a regulator of transcytosis in M cells. Nat Commun. 2017;8:14509.View ArticlePubMedPubMed CentralGoogle Scholar
  61. Mishima T, Iwabuchi K, Fujii S, Tanaka S-Y, Ogura H, Watano-Miyata K, Ishimori N, Andoh Y, Nakai Y, Iwabuchi C, Ato M, Kitabatake A, Tsutsui H, Onoé K. Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in ApoE−/− mice. Int J Mol Med. 2008;21:181–7.PubMedGoogle Scholar
  62. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer’s patches. J Exp Med. 1994;180:15–23.View ArticlePubMedGoogle Scholar
  63. Sansonetti PJ, Arondel J, Cantey JR, Prévost MC, Huerre M. Infection of rabbit Peyer’s patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium. Infect Immun. 1996;64:2752–64.PubMedPubMed CentralGoogle Scholar
  64. Jensen VB, Harty JT, Jones BD. Interactions of the invasive Pathogens Salmonella typhimurium, listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer’s patches. Infect Immun. 1998;66:3758–66.PubMedPubMed CentralGoogle Scholar
  65. Takakura I, Miyazawa K, Kanaya T, Itani W, Watanabe K, Ohwada S, Watanabe H, Hondo T, Rose MT, Mori T, Sakaguchi S, Nishida N, Katamine S, Yamaguchi T, Aso H. Orally administered prion protein is incorporated by m cells and spreads into lymphoid tissues with macrophages in prion protein knockout mice. Am J Pathol. 2011;179:1301–9.View ArticlePubMedPubMed CentralGoogle Scholar
  66. Donaldson DS, Kobayashi A, Ohno H, Yagita H, Williams IR, Mabbott NA. M cell-depletion blocks oral prion disease pathogenesis. Mucosal Immunol. 2012;5:216–25.View ArticlePubMedPubMed CentralGoogle Scholar
  67. Nair VR, Franco LH, Zacharia VM, Khan HS, Stamm CE, You W, Marciano DK, Yagita H, Levine B, Shiloh MU. Microfold cells actively translocate Mycobacterium tuberculosis to initiate infection. Cell Rep. 2016;16:1253–8.View ArticlePubMedPubMed CentralGoogle Scholar
  68. Kraehenbuhl JP, Neutra MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol. 2000;16:301–32.View ArticlePubMedGoogle Scholar
  69. Mosca A, Leclerc M, Hugot JP. Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem? Front Microbiol. 2016;7:455.Google Scholar
  70. Nochi T, Yuki Y, Matsumura A, Mejima M, Terahara K, Kim D-Y, Fukuyama S, Iwatsuki-Horimoto K, Kawaoka Y, Kohda T, Kozaki S, Igarashi O, Kiyono H. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med. 2007;204:2789–96.View ArticlePubMedPubMed CentralGoogle Scholar
  71. Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, Morita S, Tanaka K, Takaiwa F, Kiyono H. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A. 2007;104:10986–91.View ArticlePubMedPubMed CentralGoogle Scholar
  72. Shima H, Watanabe T, Fukuda S, Fukuoka S-I, Ohara O, Ohno H. A novel mucosal vaccine targeting Peyer’s patch M cells induces protective antigen-specific IgA responses. Int Immunol. 2014;26:619–25.View ArticlePubMedGoogle Scholar

Copyright

Advertisement